APA (7th ed.) Citation

Zhang, L., Yang, Q., & Zheng, Z. (2025). Cost-effectiveness analysis of cadonilimab plus chemotherapy as a first-line treatment option in HER-2-negative advanced gastric cancer. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Zhang, Longfeng, Qingsheng Yang, and Zhiwei Zheng. Cost-effectiveness Analysis of Cadonilimab Plus Chemotherapy as a First-line Treatment Option in HER-2-negative Advanced Gastric Cancer. Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Zhang, Longfeng, et al. Cost-effectiveness Analysis of Cadonilimab Plus Chemotherapy as a First-line Treatment Option in HER-2-negative Advanced Gastric Cancer. Frontiers Media S.A, 2025.